Background: The use of digital technology (DT) is increasing worldwide. Clinical trials assessing available health tools for the care of patients with inflammatory bowel disease (IBD) are sparse, with limited evidence-based outcome data. This umbrella review aims to investigate the effectiveness of DT for the care of patients with IBD and to identify areas where future work should focus on. Methods: This work followed the Joanna Briggs Institute Methodology. A search for systematic reviews published between 2012 and 2024 was completed across 8 databases and results downloaded into the “Covidence” software. Inclusion criteria were systematic reviews of randomised controlled trials (RCTs) of patients with Crohn’s Disease (CD) or ulcerative colitis (UC) of all ages, using DT for diagnostics, treatment support, monitoring, self-management, participation in research studies, compared to standard care or alternative interventions. Outcomes related to efficacy and effectiveness of digital interventions as specified in the reported studies. Prospero registration number: CRD42023417525. AMSTAR 2·0 was used for methodological quality assessment: 4 reviews were high quality, 5 were critically low quality. Findings: Sixty-nine studies were identified, with 3 duplicates removed. Nine relevant reviews were selected (5 with meta-analyses). There was no direct benefit from DT in achieving or maintaining clinical remission in IBD. The use of DT in 4 trials was associated with a reduced number of hospital attendances, supporting the use of DT as an adjuvant resource to standard clinical practice in IBD. Interpretation: the data currently available from several RCTs and systematic reviews show no superiority of DT in achieving or maintaining remission of IBD, however DT should be welcomed as an adjuvant resource contributing towards patient engagement and reduced hospital attendances. Funding: none.